´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°Á : 2022-06-11±³À°ÀÏÀÚ : 2022-06-11
±³À°Àå¼Ò : ¼¿ï º¸ÄÚ°³²¼¿ï º¼·ë
±³À°ÁÖÁ¦ :
´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ
´ã´çÀÚ : ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-720-1594
À̸ÞÀÏ :
knmd1594@daum.net ±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í »çÀüµî·Ï: Àü°øÀÇ(ȸ¿ø) 2¸¸¿ø, Àü¹®ÀÇ,±âŸ(ȸ¿ø) 4¸¸¿ø, ºñȸ¿ø 7¸¸¿ø / ´çÀϵî·Ï: Àü°øÀÇ(ȸ¿ø) 3¸¸¿ø, Àü¹®ÀÇ,±âŸ(ȸ¿ø )5¸¸¿ø, ºñȸ¿ø 8¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 09:00~10:00 Professor, please tell me your life-long experiences: Master¡¯s series 1Negative motor symptom: Weakness ÁÖÀμö(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 10:00~10:20 Positive muscle phenomena ¼º¿øÀç(ÇѾçÀÇ´ë)
±³À°½Ã°£ 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 10:20~10:40 Ptosis or ophthalmoplegia ¿À¼±¿µ(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 10:40~11:00 Bulbar Symptom (dysarthria, dysphagia) ÃÖ¼®Áø(¼¿ïÀÇ´ë)
Åä·Ð 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 11:00~11:10 Q & A ¿¬ÀÚ¸ðµÎ()
ÈÞ½Ä 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 11:10~11:20 Intermission ()
±³À°½Ã°£ 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 11:20~11:50 Positive and negative sensory symptom ¼®Èï¿(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 11:50~12:20 Dysautonomia ¿ÀÁö¿µ(°Ç±¹ÀÇ´ë)
Åä·Ð 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 12:20~12:30 Q & A ¿¬ÀÚ¸ðµÎ()
½Ä»ç 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 12:30~13:10 ÃÑȸ & Lunch, ½Å°æ±ÙÀ°Áúȯ ·¹Áö½ºÆ®¸® TFT ¼Ò°³ ½ÅÇÏ¿µ(¿¬¼¼ÀÇ´ë, ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ Ãѹ«ÀÌ»ç)
±³À°½Ã°£ 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 13:10~13:40 Electrophysiologic study ¾È¼®¿ø(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 13:40~14:10 Indication, methods and interpretation of muscle and nerve biopsy ¹Ú¿µÀº(ºÎ»êÀÇ´ë)
Åä·Ð 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 14:10~14:20 Q & A ¿¬ÀÚ¸ðµÎ()
ÈÞ½Ä 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 14:20~14:30 Intermission ()
±³À°½Ã°£ 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 14:30~15:00 Autoantibody testing in neuromuscular disroders ½ÅÇÏ¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 15:00~15:30 MRI imaging in neuromuscular disease: current and future clinical interpretations ¹ÚÁø¼º(°æºÏÀÇ´ë)
Åä·Ð 06-11 º¸ÄÚ¼¿ï°³² º¼·ë 15:30~15:40 Q & A ¿¬ÀÚ¸ðµÎ()